Onconova Therapeutics, Inc.·4

Dec 26, 9:05 AM ET

Maniar Manoj 4

4 · Onconova Therapeutics, Inc. · Filed Dec 26, 2019

Insider Transaction Report

Form 4
Period: 2019-12-20
Maniar Manoj
SVP - Product Development
Transactions
  • Award

    Stock Option (right to purchase)

    2019-12-20+43,00043,000 total
    Exercise: $0.31Exp: 2029-12-20Common Stock (43,000 underlying)
Footnotes (1)
  • [F1]These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -